Literature DB >> 32421150

Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): An Unprecedented Partnership for Unprecedented Times.

Francis S Collins1, Paul Stoffels2.   

Abstract

Entities:  

Year:  2020        PMID: 32421150     DOI: 10.1001/jama.2020.8920

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  24 in total

1.  An ethics framework for consolidating and prioritizing COVID-19 clinical trials.

Authors:  Michelle N Meyer; Luke Gelinas; Barbara E Bierer; Sara Chandros Hull; Steven Joffe; David Magnus; Seema Mohapatra; Richard R Sharp; Kayte Spector-Bagdady; Jeremy Sugarman; Benjamin S Wilfond; Holly Fernandez Lynch
Journal:  Clin Trials       Date:  2021-02-02       Impact factor: 2.486

Review 2.  Health Product Manufacturers and Innovators COVID-19 Impact Assessment: Lessons Learned and Compelling Needs.

Authors:  Mathai Mammen; Vasant Narasimhan; Richard Kuntz; Freda Lewis-Hall; Mojdeh Poul; Adam Schechter
Journal:  NAM Perspect       Date:  2022-01-18

3.  Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3).

Authors:  Daniel D Murray; Abdel G Babiker; Jason V Baker; Christina E Barkauskas; Samuel M Brown; Christina C Chang; Victoria J Davey; Annetine C Gelijns; Adit A Ginde; Birgit Grund; Elizabeth Higgs; Fleur Hudson; Virginia L Kan; H Clifford Lane; Thomas A Murray; Roger Paredes; Mahesh Kb Parmar; Sarah Pett; Andrew N Phillips; Mark N Polizzotto; Cavan Reilly; Uriel Sandkovsky; Shweta Sharma; Marc Teitelbaum; B Taylor Thompson; Barnaby E Young; James D Neaton; Jens D Lundgren
Journal:  Clin Trials       Date:  2021-10-10       Impact factor: 2.486

4.  Saving millions of lives but some resources squandered: emerging lessons from health research system pandemic achievements and challenges.

Authors:  Stephen R Hanney; Sharon E Straus; Bev J Holmes
Journal:  Health Res Policy Syst       Date:  2022-09-10

Review 5.  Distorted Human Decision-Making as a Critical Aspect of Pandemic Planning and Preparedness.

Authors:  Caroline M Poland; Tamar Ratishvili; Gregory A Poland
Journal:  Yale J Biol Med       Date:  2022-06-30

6.  A new pandemic and an old epidemic: The impact of COVID-19 and gun violence as measured by years of potential life lost in a US city.

Authors:  William B Risinger; Samuel J Pera; Neal Bhutiani; Matthew Ruther; Brian G Harbrecht; Jason W Smith; Matthew V Benns; Keith R Miller
Journal:  Surgery       Date:  2022-07-15       Impact factor: 4.348

7.  Delays in reporting and publishing trial results during pandemics: cross sectional analysis of 2009 H1N1, 2014 Ebola, and 2016 Zika clinical trials.

Authors:  Christopher W Jones; Amanda C Adams; Elizabeth Murphy; Rachel P King; Benjamin Saracco; Karen R Stesis; Susan Cavanaugh; Brian W Roberts; Timothy F Platts-Mills
Journal:  BMC Med Res Methodol       Date:  2021-06-08       Impact factor: 4.615

8.  The development of COVID-19 vaccines in the United States: Why and how so fast?

Authors:  Barbara J Kuter; Paul A Offit; Gregory A Poland
Journal:  Vaccine       Date:  2021-03-26       Impact factor: 3.641

9.  What do we do with our under-enrolled single-center COVID-19 clinical trials?

Authors:  Shing M Lee; Denise Esserman; Ken Cheung; James Dziura; Peter Peduzzi; Magdalena Sobieszczyk
Journal:  Clin Trials       Date:  2021-07-03       Impact factor: 2.599

Review 10.  Can the COVID-19 Pandemic Disrupt the Current Drug Development Practices?

Authors:  Jung-Hyun Won; Howard Lee
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.